Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.

Hamada T, Ichida K, Hosoyamada M, Mizuta E, Yanagihara K, Sonoyama K, Sugihara S, Igawa O, Hosoya T, Ohtahara A, Shigamasa C, Yamamoto Y, Ninomiya H, Hisatome I.

Am J Hypertens. 2008 Oct;21(10):1157-62. doi: 10.1038/ajh.2008.245. Epub 2008 Jul 31.

PMID:
18670416
2.

[Uricosuric agent].

Ohno I.

Nihon Rinsho. 2008 Apr;66(4):743-7. Review. Japanese.

PMID:
18409525
3.

Renal urate handling: clinical relevance of recent advances.

Anzai N, Enomoto A, Endou H.

Curr Rheumatol Rep. 2005 Jun;7(3):227-34. Review.

PMID:
15919000
4.
5.

[Primary hyperuricemia due to decreased renal uric acid excretion].

Yamauchi T, Ueda T.

Nihon Rinsho. 2008 Apr;66(4):679-81. Review. Japanese.

PMID:
18409514
6.

[Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].

Hosoyamada M, Shibasaki T, Ichida K.

Nihon Rinsho. 2006 Feb;64 Suppl 2:176-9. Review. Japanese. No abstract available.

PMID:
16523883
7.
8.

New insights into renal transport of urate.

Anzai N, Kanai Y, Endou H.

Curr Opin Rheumatol. 2007 Mar;19(2):151-7. Review.

PMID:
17278930
9.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Israili ZH.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. Review.

PMID:
10854085
10.

Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.

Anzai N, Jutabha P, Amonpatumrat-Takahashi S, Sakurai H.

Clin Exp Nephrol. 2012 Feb;16(1):89-95. doi: 10.1007/s10157-011-0532-z. Epub 2011 Nov 1. Review.

PMID:
22038265
11.

[Historical review of gout and hyperuricemia investigations].

Nakamura T.

Nihon Rinsho. 2008 Apr;66(4):624-35. Review. Japanese.

PMID:
18409506
12.

Regulation of uric acid excretion by the kidney.

Lipkowitz MS.

Curr Rheumatol Rep. 2012 Apr;14(2):179-88. doi: 10.1007/s11926-012-0240-z. Review.

PMID:
22359229
13.

Uric acid metabolism in pre-hypertension and the metabolic syndrome.

Rizzo M, Obradovic M, Labudovic-Borovic M, Nikolic D, Montalto G, Rizvi AA, Mikhailidis DP, Isenovic ER.

Curr Vasc Pharmacol. 2014;12(4):572-85. Review.

PMID:
23627979
14.

Uricosuric drugs: the once and future therapy for hyperuricemia?

Bach MH, Simkin PA.

Curr Opin Rheumatol. 2014 Mar;26(2):169-75. doi: 10.1097/BOR.0000000000000035. Review.

PMID:
24445479
15.

Renal transport of uric acid: evolving concepts and uncertainties.

Bobulescu IA, Moe OW.

Adv Chronic Kidney Dis. 2012 Nov;19(6):358-71. doi: 10.1053/j.ackd.2012.07.009. Review.

16.

[Hypouricemia, an old subject and new concepts].

Bordier L, Blanchard A, Sarret D, Hérody M, Nédélec G, Duvic C.

Presse Med. 2004 Apr 24;33(8):555-63. Review. French.

PMID:
15235514
17.

Hypertension, its treatment, hyperuricaemia and gout.

Gibson TJ.

Curr Opin Rheumatol. 2013 Mar;25(2):217-22. doi: 10.1097/BOR.0b013e32835cedd4. Review.

PMID:
23370375
18.

The molecular physiology of uric acid homeostasis.

Mandal AK, Mount DB.

Annu Rev Physiol. 2015;77:323-45. doi: 10.1146/annurev-physiol-021113-170343. Epub 2014 Nov 12. Review.

PMID:
25422986
19.
20.

The effect of angiotensin II receptor blockers on hyperuricemia.

Wolff ML, Cruz JL, Vanderman AJ, Brown JN.

Ther Adv Chronic Dis. 2015 Nov;6(6):339-46. doi: 10.1177/2040622315596119. Review.

Supplemental Content

Support Center